Consolidated Statement Of Comprehensive Income

Sumitomo Pharma Co., Ltd. - Filing #7303560

Concept 2024-04-01 to
2024-09-30
2024-04-01 to
2024-09-30
2024-04-01 to
2024-09-30
2024-04-01 to
2024-09-30
2024-04-01 to
2024-09-30
2024-04-01 to
2024-09-30
2024-04-01 to
2024-09-30
2024-04-01 to
2024-09-30
2024-04-01 to
2024-09-30
2024-04-01 to
2024-09-30
2024-04-01 to
2024-09-30
2023-04-01 to
2023-09-30
2023-04-01 to
2023-09-30
2023-04-01 to
2023-09-30
2023-04-01 to
2023-09-30
2023-04-01 to
2023-09-30
2023-04-01 to
2023-09-30
2023-04-01 to
2023-09-30
2023-04-01 to
2023-09-30
2023-04-01 to
2023-09-30
2023-04-01 to
2023-09-30
2023-04-01 to
2023-09-30
Consolidated statement of comprehensive income
Statement of comprehensive income
Profit (loss)
1,000,000 JPY
JPY
JPY
-32,229,000,000 JPY
JPY
JPY
-32,228,000,000 JPY
JPY
JPY
-32,229,000,000 JPY
JPY
JPY
JPY
-67,741,000,000 JPY
5,000,000 JPY
-67,736,000,000 JPY
JPY
JPY
-67,741,000,000 JPY
JPY
JPY
JPY
Other comprehensive income
Items that will not be reclassified to profit or loss
Remeasurements of defined benefit plans
JPY
-2,000,000 JPY
Items that may be reclassified to profit or loss
Exchange differences on translation of foreign operations
2,487,000,000 JPY
30,226,000,000 JPY
Other comprehensive income
JPY
JPY
JPY
JPY
-12,151,000,000 JPY
JPY
-9,664,000,000 JPY
-9,664,000,000 JPY
JPY
-9,664,000,000 JPY
2,487,000,000 JPY
JPY
75,780,000,000 JPY
JPY
JPY
75,780,000,000 JPY
45,556,000,000 JPY
JPY
75,780,000,000 JPY
-2,000,000 JPY
JPY
30,226,000,000 JPY
Comprehensive income
1,000,000 JPY
JPY
JPY
-32,229,000,000 JPY
-12,151,000,000 JPY
JPY
-41,892,000,000 JPY
-9,664,000,000 JPY
JPY
-41,893,000,000 JPY
2,487,000,000 JPY
JPY
75,780,000,000 JPY
-67,741,000,000 JPY
5,000,000 JPY
8,044,000,000 JPY
45,556,000,000 JPY
JPY
8,039,000,000 JPY
-2,000,000 JPY
JPY
30,226,000,000 JPY
Comprehensive income attributable to
Owners of parent
-41,893,000,000 JPY
8,039,000,000 JPY
Non-controlling interests
1,000,000 JPY
5,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.